Initiation, Switching, and Cessation of Psoriasis Treatments Among Patients with Moderate to Severe Psoriasis in the United States
Crossref DOI link: https://doi.org/10.1007/s40261-017-0508-1
Published Online: 2017-03-16
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Armstrong, April W.
Koning, J. Will
Rowse, Simon
Tan, Huaming
Mamolo, Carla
Kaur, Mandeep
Funding for this research was provided by:
Pfizer
License valid from 2017-03-16